Intelicanna (Israel) Today
| INTL Stock | 56.00 1.80 3.11% |
Performance3 of 100
| Odds Of DistressLess than 38
|
Intelicanna is trading at 56.00 as of the 14th of December 2024, a 3.11 percent decrease since the beginning of the trading day. The stock's open price was 57.8. Intelicanna has about a 38 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 14th of November 2024 and ending today, the 14th of December 2024. Click here to learn more.
Moving against Intelicanna Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Intelicanna Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Intelicanna's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Intelicanna or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
Intelicanna (INTL) is traded on Tel Aviv Stock Exchange in Israel and employs 40 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Intelicanna's market, we take the total number of its shares issued and multiply it by Intelicanna's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Intelicanna operates under Healthcare sector and is part of Drug Manufacturers-Specialty & Generic industry. The entity has 46.96 M outstanding shares.
Intelicanna generates negative cash flow from operations
Check Intelicanna Probability Of Bankruptcy
Ownership AllocationIntelicanna has a total of 46.96 Million outstanding shares. Intelicanna secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Intelicanna Ownership Details
Intelicanna Risk Profiles
Although Intelicanna's alpha and beta are two of the key measurements used to evaluate Intelicanna's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.8 | |||
| Semi Deviation | 4.17 | |||
| Standard Deviation | 5.69 | |||
| Variance | 32.41 |
Intelicanna Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Intelicanna without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Intelicanna Corporate Management
Elected by the shareholders, the Intelicanna's board of directors comprises two types of representatives: Intelicanna inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intelicanna. The board's role is to monitor Intelicanna's management team and ensure that shareholders' interests are well served. Intelicanna's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intelicanna's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ilanit CPA | CFO Fin | Profile | |
| Zbigniew Brzezinski | Managing Poland | Profile | |
| Haim Weiss | Chief Officer | Profile | |
| Ori Weiss | CEO Director | Profile | |
| Zeev Ahronson | Project Procurement | Profile | |
| Elijah Weiss | Director Growth | Profile | |
| Mally BitzurParnes | Chief Israel | Profile |
Other Information on Investing in Intelicanna Stock
Intelicanna financial ratios help investors to determine whether Intelicanna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intelicanna with respect to the benefits of owning Intelicanna security.